| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.96▼ | 0.97▼ | 0.97▼ | 1.13▼ | 1.18▼ |
| MA10 | 0.97▼ | 1.01▼ | 1.05▼ | 1.16▼ | 1.25▼ |
| MA20 | 1.03▼ | 1.12▼ | 1.12▼ | 1.21▼ | 1.17▼ |
| MA50 | 1.14▼ | 1.13▼ | 1.15▼ | 1.29▼ | 1.16▼ |
| MA100 | 1.14▼ | 1.18▼ | 1.20▼ | 1.17▼ | 1.19▼ |
| MA200 | 1.19▼ | 1.25▼ | 1.27▼ | 1.18▼ | 2.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.021▼ | -0.025▼ | -0.013▼ | -0.023▼ |
| RSI | 30.957▼ | 26.660▼ | 30.638▼ | 30.054▼ | 39.282▼ |
| STOCH | 12.539▼ | 27.244 | 19.736▼ | 21.589 | 27.194 |
| WILL %R | -100.000▼ | -84.903▼ | -86.244▼ | -88.085▼ | -89.725▼ |
| CCI | -101.281▼ | -64.519 | -75.611 | -291.382▼ | -174.107▼ |
| RSI | $RNXT RSI(14) Crossed Below 50 | Set Alert |
| ▼ MACD | $RNXT MACD(12,26,9) Crossed Below Signal Line | Set Alert |
| MA | $RNXT Price Crossed Below MA(200) | Set Alert |
| MA | $RNXT Price Crossed Below MA(13) | Set Alert |
| MA | $RNXT Price Crossed Below MA(7) | Set Alert |
| ▼ GAP | $RNXT Open Gap Down %5 | Set Alert |
| ▼ GAP | $RNXT Open Gap Down %3 | Set Alert |
| ▼ GAP | $RNXT Open Gap Down %2 | Set Alert |
| ▼ BREAK | $RNXT Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $RNXT Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $RNXT Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $RNXT Price Breaks 10 Days Low | Set Alert |
| CDL | $RNXT Evening Star Candlestick Pattern Detected | Set Alert |
|
Friday, August 15, 2025 12:36 AM
RenovoRx Inc (RNXT) reports promising sales figures and trial progress, despite challenges in commercialization and market expansion.
|
|
Wednesday, August 06, 2025 05:43 AM
RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath Four active cancer center customers are ...
|
|
Sunday, July 27, 2025 10:29 PM
RenovoRx, Inc. (Nasdaq: RNXT) is a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, U.S. Food and Drug Administration (FDA ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.00 | 1.03 | 0.90 | 0.956 | 1,221,300 |
| 14/08/25 | 1.25 | 1.32 | 1.195 | 1.24 | 263,925 |
| 13/08/25 | 1.10 | 1.37 | 1.10 | 1.22 | 467,800 |
| 12/08/25 | 1.14 | 1.25 | 1.10 | 1.10 | 259,400 |
| 11/08/25 | 1.13 | 1.15 | 1.11 | 1.115 | 174,700 |
| 08/08/25 | 1.215 | 1.215 | 1.11 | 1.14 | 194,039 |
| 07/08/25 | 1.23 | 1.24 | 1.17 | 1.20 | 40,800 |
| 06/08/25 | 1.20 | 1.24 | 1.20 | 1.20 | 84,358 |
| 05/08/25 | 1.20 | 1.24 | 1.20 | 1.22 | 41,655 |
| 04/08/25 | 1.22 | 1.25 | 1.205 | 1.21 | 73,217 |
|
|
||||
|
|
||||
|
|